Fineline Cube

Follow:
14404 Articles
Neurodawn Pharmaceutical Secures Hundreds of Millions in Series C Financing
CompanyDeals

Neurodawn Pharmaceutical Secures Hundreds of Millions in Series C Financing

Suzhou Basecare Medical's BKA210 Receives Marketing Approval in Jiangsu Province
CompanyMedical Device

Suzhou Basecare Medical’s BKA210 Receives Marketing Approval in Jiangsu Province

Reprogenix Secures Over RMB100 Million in Series A Financing Led by China Venture Capital
CompanyDeals

Reprogenix Secures Over RMB100 Million in Series A Financing Led by China Venture Capital

Novo Nordisk's Semaglutide Meets Primary Endpoints in ESSENCE Phase III Study for MASH
CompanyDrug

Novo Nordisk’s Semaglutide Meets Primary Endpoints in ESSENCE Phase III Study for MASH

Jiuzhitang Co., Ltd Announces Clinical Clearance for Volagidemab in Type 1 Diabetes
CompanyDrug

Jiuzhitang Co., Ltd Announces Clinical Clearance for Volagidemab in Type 1 Diabetes

Shenzhen Chipscreen Biosciences Receives NMPA Approval for Chiauranib Clinical Study
CompanyDrug

Shenzhen Chipscreen Biosciences Receives NMPA Approval for Chiauranib Clinical Study

Innovent Biologics Halts Subscription Agreement with Lostrancos Ventures
CompanyDeals

Innovent Biologics Halts Subscription Agreement with Lostrancos Ventures

China's CDE Releases 88th Batch of Reference Preparations for Generic Drug Evaluation
Policy / Regulatory

China’s CDE Releases 88th Batch of Reference Preparations for Generic Drug Evaluation

AstraZeneca's China President Leon Wang Confirmed to Assist in Investigation Amid Fraud Allegations
Company

AstraZeneca’s China President Leon Wang Confirmed to Assist in Investigation Amid Fraud Allegations

Novartis' Trispecific Antibody PIT565 Secures NMPA Approval for Clinical Trial
CompanyDrug

Novartis’ Trispecific Antibody PIT565 Secures NMPA Approval for Clinical Trial

Chipscreen Biosciences' Tivozanib Secures NMPA Approval for ES-SCLC Phase III Trial
CompanyDrug

Shenzhen Chipscreen Biosciences’ Tivozanib Secures NMPA Approval for ES-SCLC Phase III Trial

Humanwell Healthcare Receives NMPA Approval for Compound Sodium Lactate Ringer's Injection
CompanyDrug

Humanwell Healthcare Receives NMPA Approval for Compound Sodium Lactate Ringer’s Injection